GB1016968A - Piperazine esters of ª‡-substituted 1-naphthylacetic acids - Google Patents
Piperazine esters of ª‡-substituted 1-naphthylacetic acidsInfo
- Publication number
- GB1016968A GB1016968A GB17604/64A GB1760464A GB1016968A GB 1016968 A GB1016968 A GB 1016968A GB 17604/64 A GB17604/64 A GB 17604/64A GB 1760464 A GB1760464 A GB 1760464A GB 1016968 A GB1016968 A GB 1016968A
- Authority
- GB
- United Kingdom
- Prior art keywords
- piperazine
- substituted
- reacting
- propanediol
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention comprises compounds of general formula <FORM:1016968/C2/1> where R is hydrogen or C1 to C5 alkyl group and acid addition salts thereof; and the preparation thereof by reacting a piperazine derivative of the formu'a <FORM:1016968/C2/2> with a 1-naphthylacetic acid derivative of the formula <FORM:1016968/C2/3> where X and Y represent groups which are able to react together to form divalent -O-CH2-CH2-radicals, for example (1) reacting an acid halide of an a -substituted or unsubstituted 1-naphthyl acetic acid with N,N1-d -(b -hydroxyethyl)-piperazine; (2) reacting a b -halo ethyl ester of an a -substituted or unsubstituted 1-naphthyl acetic acid with piperazine; (3) transesterifying the esters, preferably the alkyl esters, of a -substituted or unsubstituted 1-naphthyl acetic acids with N,N1-di-(b -hydroxyethyl)-piperazine; and (4) reacting an alkali metal salt of an a -substituted or unsubstituted 1-naphthyl acetic acid with an N,N1-di-(b -haloethyl)piperazine. The compounds of the invention may be mixed with solubility promoters such as metamizole, urea, nicotinamide, nicotinamide ascorbate, piperazine, hexamethylene - tetramine, antipyrene, acetamide, dimethylacetamide, coramine, and compounds containing a -O-CH2-CH(OH-CH2OH group such as 3 - (2 - methoxy - phenoxy) - 1,2 - propanediol and 3-(2-methyl, chloro- and methoxy-4-propionyl - phenoxy) - 1,2 - propanediol. Acid chlorides of the general formula <FORM:1016968/C2/4> wherein R is H, ethyl, n-propyl or n-butyl, are produced by reacting the corresponding free carboxylic acids and thionyl chloride.ALSO:Pharmaceutical compositions having spasmolytic activity contain as their active ingredient compounds of the formula: <FORM:1016968/A5-A6/1> wherein, R represents hydrogen or straight chain C1 to C5 alkyl, and acid addition salts thereof. The compositions which may be adapted for oral, rectal or parenteral administration take the form of tablets, dragees, capsules, suppositories, ampoules, suspensions, syrups, solutions, injectable liquids, linctuses, emulsions, drops or suspensions. Solubility promoters such as metamizole, urea, nicotinamide, nicotinamide ascorbate, piperazine, hexamethylene-tetramine, antipyrene, acetamide, dimethylacetamide coramine and compounds containing a -O-CH2-CH(OH)-CH2OH group such as 3-(2-methoxy-pheroxy)-1, 2-propanediol and 3-(2-methyl, chloro and methoxy-4-propionyl-phenoxy)-1, 2-propanediol may be included.
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL124129D NL124129C (en) | 1964-04-28 | ||
GB17604/64A GB1016968A (en) | 1964-04-28 | 1964-04-28 | Piperazine esters of ª‡-substituted 1-naphthylacetic acids |
BR164391/64A BR6464391D0 (en) | 1964-04-28 | 1964-11-17 | PROCESS FOR THE PREPARATION OF NEW I-NAFTYLACETIC ESTERS OF DIETANOL PIPERAZINE |
US412859A US3338902A (en) | 1964-04-28 | 1964-11-20 | Esters of piperazine 1, 4-diethanol |
IL22496A IL22496A (en) | 1964-04-28 | 1964-11-23 | N,n1-di-(beta-hydroxyethyl)piperazine esters of 1-naphthyl alkanoic acids |
NL6413857A NL6413857A (en) | 1964-04-28 | 1964-11-27 | |
FR996522A FR4374M (en) | 1964-04-28 | 1964-11-27 | |
DE19641445959 DE1445959A1 (en) | 1964-04-28 | 1964-11-27 | Process for the preparation of piperazine derivatives |
FR996526A FR1476516A (en) | 1964-04-28 | 1964-11-27 | New nude esters. nu-di (beta-hydroxyethyl) piperazine and process for their preparation |
ES0306519A ES306519A1 (en) | 1964-04-28 | 1964-11-28 | Esters of piperazine 1, 4-diethanol |
BE656442D BE656442A (en) | 1964-04-28 | 1964-11-30 | |
CH1540964A CH448099A (en) | 1964-04-28 | 1964-11-30 | Process for the preparation of 1-naphthyl-acetic acid esters of N, N'-di- (B-hydroxyethyl) piperazine |
AT1011864A AT254197B (en) | 1964-04-28 | 1964-11-30 | Process for the preparation of new diesters of N, N'-di (β-hydroxyethyl) piperazine with optionally α-substituted 1-naphthylacetic acids |
CH1047969A CH541567A (en) | 1964-04-28 | 1969-07-09 | 1,4-bis(hydroxyethyl)piperazine diesters - with myolytic-type spasmolytic activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB17604/64A GB1016968A (en) | 1964-04-28 | 1964-04-28 | Piperazine esters of ª‡-substituted 1-naphthylacetic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1016968A true GB1016968A (en) | 1966-01-12 |
Family
ID=10098067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB17604/64A Expired GB1016968A (en) | 1964-04-28 | 1964-04-28 | Piperazine esters of ª‡-substituted 1-naphthylacetic acids |
Country Status (9)
Country | Link |
---|---|
US (1) | US3338902A (en) |
AT (1) | AT254197B (en) |
BE (1) | BE656442A (en) |
BR (1) | BR6464391D0 (en) |
CH (1) | CH448099A (en) |
ES (1) | ES306519A1 (en) |
FR (1) | FR4374M (en) |
GB (1) | GB1016968A (en) |
IL (1) | IL22496A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2996506A (en) * | 1961-08-15 | Hcxchb | ||
US2995554A (en) * | 1958-09-08 | 1961-08-08 | Lakeside Lab Inc | Substituted glycolic acid esters of 1, 4-bis-(hydroxyalkyl)-piperazines |
-
1964
- 1964-04-28 GB GB17604/64A patent/GB1016968A/en not_active Expired
- 1964-11-17 BR BR164391/64A patent/BR6464391D0/en unknown
- 1964-11-20 US US412859A patent/US3338902A/en not_active Expired - Lifetime
- 1964-11-23 IL IL22496A patent/IL22496A/en unknown
- 1964-11-27 FR FR996522A patent/FR4374M/fr not_active Expired
- 1964-11-28 ES ES0306519A patent/ES306519A1/en not_active Expired
- 1964-11-30 AT AT1011864A patent/AT254197B/en active
- 1964-11-30 CH CH1540964A patent/CH448099A/en unknown
- 1964-11-30 BE BE656442D patent/BE656442A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CH448099A (en) | 1967-12-15 |
IL22496A (en) | 1968-12-26 |
AT254197B (en) | 1967-05-10 |
ES306519A1 (en) | 1965-04-01 |
BR6464391D0 (en) | 1973-08-07 |
US3338902A (en) | 1967-08-29 |
BE656442A (en) | 1965-05-31 |
FR4374M (en) | 1966-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1016968A (en) | Piperazine esters of ª‡-substituted 1-naphthylacetic acids | |
GB1237059A (en) | Anti-virally effective quinoline derivatives | |
ES380859A1 (en) | Dibenzo(d,g)(1,3)dioxocin-6-carboxylic acids, esters and salts | |
GB981192A (en) | Improvements in or relating to 4 hydroxytryptamine esters | |
ES479570A1 (en) | 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity | |
GB984018A (en) | Basic esters of 1-benzoxacycloalkanecarboxylic acids | |
GB915259A (en) | 4-halo-3-sulfamoylbenzoic acid esters and methods for producing same | |
GB1099209A (en) | 5-sulfamoylanthranilic acid derivatives | |
GB1462676A (en) | Substituted esters of n-4-quinolyl-anthranilic acids | |
GB940701A (en) | Novel therapeutic salts of steroid compounds and processes for their manufacture | |
US3160557A (en) | Method of producing anti-tussive action with 2-allyloxy-benzoic acid derivatives | |
GB1041524A (en) | Phenyl-indandiones | |
GB982072A (en) | Benzothiadiazine-1,1-dioxides and processes for their manufacture | |
GB1504683A (en) | Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives | |
GB1029213A (en) | Chromone derivatives | |
GB1082184A (en) | Thiamine derivatives | |
GB1391534A (en) | Thiazoloquinolines and process for preparing them | |
GB1237062A (en) | ESTERS OF alpha-(1-SUBSTITUTED-3-PYRROLIDINYL)-alpha-PHENYL-ACETIC ACID | |
GB1000803A (en) | New uracil derivatives and process for their production | |
GB1001354A (en) | Substituted anthranilic acid esters | |
GB1075300A (en) | N-substituted-5-sulfamoyl-4-trifluoromethylanthranilic acids | |
GB717516A (en) | Manufacture of new alkylaminobenzoic acid esters and inorganic acid salts thereof | |
GB1132057A (en) | 6-amino penicillanic acid derivatives | |
GB970941A (en) | New quinoline derivatives and process for the preparation thereof | |
GB1107036A (en) | Esters of dibenzocycloheptenyl-carboxylic acids |